Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Sells 4,635 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Intuitive Surgical Stock Up 0.1 %

NASDAQ:ISRG opened at $574.14 on Wednesday. The stock has a market cap of $204.50 billion, a price-to-earnings ratio of 92.31, a PEG ratio of 5.19 and a beta of 1.39. The company’s 50 day moving average price is $548.00 and its 200-day moving average price is $506.12. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Institutional Trading of Intuitive Surgical

Several institutional investors have recently added to or reduced their stakes in the business. Mirador Capital Partners LP boosted its position in shares of Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares during the last quarter. M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $82,517,000. Exome Asset Management LLC raised its holdings in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, Consolidated Planning Corp lifted its position in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ISRG has been the subject of a number of recent analyst reports. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday. Mizuho boosted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Finally, Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.